• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

NxStage Medical Inc

+ Add to Watchlist

N5X:GR

10.799 EUR 0.166 1.56%

As of 02:20:05 ET on 10/21/2014.

Snapshot for NxStage Medical Inc (N5X)

Open: 10.799 Day's Range: 10.799 - 10.799 Volume: 0
Previous Close: 10.633 52wk Range: 6.587 - 10.799 1-Yr Rtn: +6.53%

Stock Chart for N5X

No chart data available.
  • N5X:GR 10.799
  • 1D
  • 1M
  • 1Y
10.633
Interactive N5X Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for N5X

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4490
Est. PEG Ratio -
Market Cap (M EUR) 667.66
Shares Outstanding (M) 61.83
30 Day Average Volume 20
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for N5X

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for N5X

NxStage Medical, Inc. is medical device company that develops, manufactures, and markets systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. The Company's primary product, the NxStage System One, is a small, portable hemodialysis system.

Jeffrey H Burbank "Jeff"CEO/FounderJoseph E Turk Jr "Joe"President
Robert S BrownPres:Nxstage Kidney CareMatthew W TowseSenior VP/CFO/Treasurer
More Company Profile & Key Executives for N5X

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil